Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Claudia, Marini"'
Autor:
Piero Gentile, Claudia Marini, Enrico Ammirati, Enrico Perna, Gianluigi Saponara, Andrea Garascia, Luciana D'Angelo, Alessandro Verde, Grazia Foti, Gabriella Masciocco, Maria Frigerio, Manlio Cipriani
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4322-4327 (2021)
Abstract Background Patients in heart transplantation (HTx) waiting list for advanced heart failure (HF) are susceptible to acute deterioration refractory to standard HF medical therapies. Limited data are available on long‐term in‐hospital conti
Externí odkaz:
https://doaj.org/article/d2bb8de0b2a54817897b73e4eb4eb0f4
Autor:
Paolo Severino, Andrea D'Amato, Andrea Saglietto, Fabrizio D'Ascenzo, Claudia Marini, Marco Schiavone, Nicolò Ghionzoli, Filippo Pirrotta, Francesca Troiano, Margherita Cannillo, Marco Mennuni, Andrea Rognoni, Francesco Rametta, Alessandro Galluzzo, Gianluca Agnes, Fabio Infusino, Mariateresa Pucci, Carlo Lavalle, Luca Cacciotti, Paul J. Mather, Walter Grosso Marra, Fabrizio Ugo, Giovanni Forleo, Maurizio Viecca, Nuccia Morici, Giuseppe Patti, Gaetano M. De Ferrari, Alberto Palazzuoli, Massimo Mancone, Francesco Fedele
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 4182-4188 (2020)
Abstract Aims The recent coronavirus disease 19 (COVID‐19) pandemic outbreak forced the adoption of restraint measures, which modified the hospital admission patterns for several diseases. The aim of the study is to investigate the rate of hospital
Externí odkaz:
https://doaj.org/article/24de5fd6316e42d88776f9907d5745f0
Autor:
Alberto Cereda, Alessandra Laricchia, Claudia Marini, Gabriele Franchina, Barbara Conconi, Stefano Lucreziotti
Publikováno v:
European Heart Journal Supplements. 24
Introduction Landiolol is a recently innovated ultra-short-acting beta-blocker. Landiolol is the only beta-blocker with a specific dose recommendation for patients with cardiac dysfunction and acute atrial fibrillation (Class I recommendation accordi
Autor:
Antonio Gabriele Franchina, Alessandro Minardi, Claudia Marini, Floriana Calì, Lorenzo Fiorista, Massimo Pala, Alberto Cereda, Stefano Lucreziotti
Publikováno v:
European Heart Journal Supplements. 24
This clinical case shows the diagnostic challenge and the management of a 79 y-o male with arterial hypertension, tabagism, obesity and a recent hospitalization for infero-lateral STEMI undergoing primary PCI of Right Coronary Artery with 2 DES and f
Autor:
Enrico Perna, Manlio Cipriani, Grazia Foti, Gianluigi Saponara, Maria Frigerio, Enrico Ammirati, G. Masciocco, Claudia Marini, Alessandro Verde, Piero Gentile, Luciana D'Angelo, Andrea Garascia
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 5, Pp 4322-4327 (2021)
ESC Heart Failure, Vol 8, Iss 5, Pp 4322-4327 (2021)
Background Patients in heart transplantation (HTx) waiting list for advanced heart failure (HF) are susceptible to acute deterioration refractory to standard HF medical therapies. Limited data are available on long‐term in‐hospital continuous int
Autor:
Franziska Altmüller, Santosh Pothula, Anil Annamneedi, Saeideh Nakhaei-Rad, Carolina Montenegro-Venegas, Eneko Pina-Fernández, Claudia Marini, Monica Santos, Denny Schanze, Dirk Montag, Mohammad R Ahmadian, Oliver Stork, Martin Zenker, Anna Fejtova
Publikováno v:
PLoS Genetics, Vol 13, Iss 6, p e1006843 (2017)
[This corrects the article DOI: 10.1371/journal.pgen.1006684.].
Externí odkaz:
https://doaj.org/article/9f508d33e6cd48faa1a9521ab6557376
Autor:
Franziska Altmüller, Santosh Pothula, Anil Annamneedi, Saeideh Nakhaei-Rad, Carolina Montenegro-Venegas, Eneko Pina-Fernández, Claudia Marini, Monica Santos, Denny Schanze, Dirk Montag, Mohammad R Ahmadian, Oliver Stork, Martin Zenker, Anna Fejtova
Publikováno v:
PLoS Genetics, Vol 13, Iss 3, p e1006684 (2017)
Noonan syndrome (NS) is characterized by reduced growth, craniofacial abnormalities, congenital heart defects, and variable cognitive deficits. NS belongs to the RASopathies, genetic conditions linked to mutations in components and regulators of the
Externí odkaz:
https://doaj.org/article/4d79c075e1a8490e85b7c3fa7893b496
Autor:
Maurizio Bottiroli, Jonica Campolo, Nuccia Morici, Alice Sacco, Sergio Leonardi, Manlio Cipriani, Serafina Valente, Gianfranco Frigerio, Luisa Cacciavillani, Fabrizio Oliva, Matteo Rota, Federico Pappalardo, Elena Corrada, Maria Frigerio, Gaetano M. De Ferrari, Guido Tavazzi, Daniele Grosseto, Claudia Marini
Publikováno v:
American Heart Journal. 233:39-47
Background Cardiogenic shock (CS) is a systemic disorder associated with dismal short-term prognosis. Given its time-dependent nature, mechanical circulatory support may improve survival. Intra-aortic balloon pump (IABP) had gained widespread use bec
Autor:
Rosa Cardenal-Piris, Felipe Fernández-Vázquez, Creighton W. Don, Francesca Valentini, Simon Parlow, Nicolina Conti, Mohamad A. Alkhouli, Alessandra Berardini, Dan Haberman, Amos Levi, Claudio Rapezzi, Marino Labinaz, Marta Bargagna, Luca Branca, Thierry G. Mesana, Benjamin Hibbert, Elena Biagini, Tomás Benito-González, Nicola Buzzatti, Risa Shorr, Richard G. Jung, Davide Schiavi, Sinisa Markovic, Marianna Adamo, José Francisco Díaz Fernández, Federico Pappalardo, Pietro Di Santo, Trevor Simard, Alessandra Sala, Christopher P. Kovach, Vincent Chan, Mony Shuvy, Claudia Marini, Paolo Denti, Mark Hynes, Rodrigo Estévez-Loureiro, Kelsey M. Flint, Ana J. Manovel, Maurizio Taramasso
Publikováno v:
JACC: Cardiovascular Interventions. 14:1-11
Objectives: The aim of this study was to evaluate the outcome of transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant mitral regurgitation (MR). Background: Patients in cardiogenic shock with severe MR have a po
Autor:
Evelina Toscano, Vittorio Pazzanese, Claudia Marini, Barbara Bellini, Mario Gramegna, Ludovica Bognoni, Matteo Montorfano, Mauro Carlino, Lorenzo Azzalini, Silvia Moscardelli
Publikováno v:
The American Journal of Cardiology. 125:182-188
The durability of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is uncertain. We aimed to compare the long-term outcomes of CTO PCI with those of complex non-CTO PCI. We built a single-center registry including all patients w